COVID Drugs

Covid-19 Drug Shows Positive Results In Preliminary Testing

An experimental Covid-19 drug that promises to be a kind of Tamiflu for the pandemic had positive results in a preliminary study, one of the drug’s developers said, says an article published in The Wall Street Journal.

Development of the Pill 

The pill, which is being developed by Ridgeback Biotherapeutics LP and Merck & Co., significantly reduced infectious virus in subjects in a mid-stage study after five days of treatment, Ridgeback is reporting at a virtual meeting of infectious-disease...

https://mfame.guru/covid-19-drug-shows-positive-results-in-preliminary-testing/

The Dubious Case of Remdesivir, The First FDA Approved COVID Drug

  • Within weeks of Remdesivir trial data publishing, GiLead signed a EU manufacturing deal and got the drug approved by FDA.
  • The dubious circumstances of the first FDA approved covid drug shows how the company exploited and gained advantage.
  • Breaches and badmouthing of WHO’s solidarity trial is a noted problem
  • Added to this the lack of inclusion of critical study evidences and the absence of any outer panel expert debate for approval makes the matter dubious.

October was a good month for Gilead...

https://mfame.guru/the-dubious-case-of-remdesivir-the-first-fda-approved-covid-drug/

World’s Largest Vaccine Makers To Begin Human Testing In The US With Eye On Rollout In Early 2021

  • GlaxoSmithKlineand Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time.
  • Furthermore, results of the trial are expected to arrive in early December 2020.
  • The two pharmaceutical companies are scaling up their manufacturing units to achieve an all time high of $1bn doses in production.
  • In Addition, the US government agreed to provide funds to speed up the development process, in return for 100m doses of the vaccine, if effective.
  • They are also looking to...

https://mfame.guru/worlds-largest-vaccine-makers-to-begin-human-testing-in-the-us-with-eye-on-rollout-in-early-2021/

AI Drug Development Strategies Speed Up COVID Drug Manufacturing

An employee checks Arbidol capsules as they move along the production line at OAO Pharmstandard’s Leksredstva drug manufacturing unit in Kursk, Russia, on Friday, Aug. 16, 2013. Pharmstandard said it will offer $590 million in cash and shares for Bever Pharmaceutical Pte. Ltd. in a deal that will give Pharmstandard board member Alexander Shuster an 18.7 percent stake in Russia’s biggest drugmaker. Photographer: Andrey Rudakov/Bloomberg via Getty Images
  • As the pandemic medicines are unleashed...

https://mfame.guru/ai-drug-development-strategies-speed-up-covid-drug-manufacturing/

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon
By subscribing, you agree with our privacy policy and our terms of service.